ArticleNature protocols2020
Synthesis of high-molar-activity [
Article in Nature protocols, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 48 citations in OpenAlex.
- Article
- Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2026Review
- CD98 Light Chain LAT1 Tracers in PET-CT Diagnosis of Cancer Patients.Anti-cancer agents in medicinal chemistry · 2026Review
- Highlight selection of radiochemistry and radiopharmacy developments by editorial board.EJNMMI radiopharmacy and chemistry · 2025Review
- Exploring the radiochemistry of PARP inhibitors: a new era in therapy and imaging.EJNMMI radiopharmacy and chemistry · 2025Review
- Ethyl Pinacol Boronates as Advantageous Precursors for Copper-Mediated Radiofluorination.Organic letters · 2025Article
- Protective Group-Dependent Iridium-Catalyzed CH Borylations of Levodopa.The Journal of organic chemistry · 2025Article
- Copper-mediated radiochemistry: historical impact, current trends, and future possibilities.Npj imaging · 2025Review
- Complex Diagnostic Challenges in Glioblastoma: The Role ofPharmaceuticals (Basel, Switzerland) · 2024Review
- Step-by-step optimisation of the radiosynthesis of the brain HDAC6 radioligand [EJNMMI radiopharmacy and chemistry · 2024Article
- Manufacturing 6-[Organic letters · 2024Article
- Tandem Iridium-Catalyzed C-H Borylation/Copper-Mediated Radiofluorination of Aromatic C-H Bonds with [Methods in molecular biology (Clifton, N.J.) · 2024Article
- One-Pot Formal Carboradiofluorination of Alkenes: A Toolkit for Positron Emission Tomography Imaging Probe Development.Journal of the American Chemical Society · 2023Article
- Radiochemistry for positron emission tomography.Nature communications · 2023Review
- Next Generation Copper Mediators for the Efficient Production ofChemistry (Weinheim an der Bergstrasse, Germany) · 2023Article
- multi-patient dose synthesis of [18F]Flumazenil via a copper-mediatedEJNMMI radiopharmacy and chemistry · 2022Article
- Targeting Amyloids with [Molecular pharmaceutics · 2022Article
- Arene radiofluorination enabled by photoredox-mediated halide interconversion.Nature chemistry · 2022Article
- Recent Advances in Synthetic Methodologies to Form C-Frontiers in chemistry · 2022Review
- Mild, Organo-Catalysed Borono-Deamination as a Key to Late-Stage Pharmaceutical Precursors andFrontiers in chemistry · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 4 institutions in 4 countries.
Funding
Abstract
[
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.